Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist
- Conditions
- Arthroscopic Surgery
- Interventions
- Device: OstenilProcedure: Standard arthroscopic procedure
- Registration Number
- NCT01254682
- Lead Sponsor
- TRB Chemedica AG
- Brief Summary
The primary objective of this study is to evaluate the efficacy and safety of Ostenil application (1% hyaluronan) after arthroscopy of the wrist.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 140
- Male and female patients between 18 and 80 years of age
- Minimum pain score of 2 according to modified Mayo Wrist Score
- Patients in good general health/nutritional condition
- Signed written informed consent
- Alcohol / drug abuse, drug addiction or neurotic personality disorder; patients with mental illness or suicidal tendency
- Severe intercurrent illness (like uncontrolled diabetes mellitus or thyroid disease, carcinoma,...)
- Fertile women without medically secured contraception(hysterectomy, sterilization, contraceptives,...)
- Subjects having a high probability of non compliance to the study procedures according to investigator's judgement (like illiteracy, insufficient German linguistic knowledge)
- Contraindication for the use of one of the investigational products or for the scheduled anesthesia
- Concomitant or previous participation in a clinical trial within the last 3 months
- Intraarticular treatment with a sodium hyaluronate-based product within the last 6 months
- Intraarticular treatment by the use of corticoid containing substance within the last 3 months
- Concomitant illness or injury influencing study evaluation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Hyaluronic acid sodium salt (1%, 20mg/2ml) Ostenil - Standard arthroscopic procedure Standard arthroscopic procedure -
- Primary Outcome Measures
Name Time Method Inter-group comparison of Mayo total wrist score in subjects with or without post-arthroscopic hyaluronan treatment 3 months after arthroscopic surgery. Baseline and 3 months Mayo wrist score evaluation consisting of 4 sections:
* Maximal grip strength on injured side (compared to maximal strength of contralateral side, measured by 4-point scale, ranking from '0' for minimal to '30' for maximal strength)
* Range of motion (measured by 4-point scale, ranking from '0' for minimal to '20' for maximal mobility)
* Pain (measured by 4-point scale, ranking from '0' for maximal to '20' for minimal pain)
* Function in daily activities (measured by 4-point scale, ranking from '0' for minimal to '30' for maximal function)
- Secondary Outcome Measures
Name Time Method Inter-group comparison of Mayo total wrist score in subjects with or without post-arthroscopic hyaluronan treatment. Measured during the 6-month duration of participation Disabilities of the arm, shoulder, and hand (DASH) outcome measure Measured during the 6-month duration of participation Grip strength Measured during the 6-month duration of participation Visual analogue scale of pain (VAS; 100 mm) Measured during the 6-month duration of participation Clinical Global Impression (CGI) Measured during the 6-month duration of participation Inter-group comparison of Mayo wrist subscores in subjects with or without post-arthroscopic hyaluronan treatment. Measured during the 6-month duration of participation * Maximal grip strength on injured side (compared to contralateral side)
* Range of motion
* Pain
* Function in daily activitiesNumber of subjects with Adverse Events as a measure of safety and tolerability Measured during the 6-month duration of participation
Trial Locations
- Locations (1)
Orthopädische Gemeinschaftspraxis
🇩🇪Straubing, Bavaria, Germany